Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up spending, Mercer's latest survey reveals.

The Centers for Disease Control and Prevention and the U.S. the Food and Drug Administration are investigating a Salmonella ...

In a survey of 2,000 single adults ages 18 to 91 conducted by Indiana University, among those taking GLP-1 drugs to lose ...

Researchers at St. Louis University followed 110 men with obesity, many with type 2 diabetes, who were being treated with GLP ...

Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill ...

Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...

The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

KANSAS CITY — The concept of food as medicine is catching on among consumers who are taking health and wellness into their ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an incr ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...